Previously, a prognostic model comprising three PRGs (CASP4, CASP9, and NOD2 (encoding nucleotide binding oligomerization domain containing 2)) was constructed to predict the outcomes of patients with glioma (38). Here, NOD2 is linked to central nervous system cancer.